Karen Soares, the Chief Legal Officer of Clover Health Investments, Corp., has sold 14,673 shares of Class A Common Stock to meet tax obligations related to her restricted stock units. This transaction, which took place on October 15, 2026, underscores the ongoing vesting of equity awards within the healthcare sector.
The sale was executed at a weighted average price of $4.68 per share, with the sales mandated by Clover Health's election under its equity incentive plans. According to the filing, these sales do not represent discretionary trades but are required to cover tax withholding obligations.
Background
Clover Health, identified by CIK 0001801170, operates in the hospital and medical service plans sector. The company was previously known as Clover Health Investments, Corp. and has undergone several name changes, including its former identity as Social Capital Hedosophia Holdings Corp. III. The company is incorporated in Delaware and has its business address in Jersey City, New Jersey.
What the Filing Says
The SEC filing, accession number 0001801170-26-000282, details the sale of shares by Soares, stating, "The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024." This highlights the structured nature of equity compensation within the firm.
Impact
This transaction may impact both Soares personally and the broader market perception of Clover Health. As a key officer, her actions could influence investor sentiment and the company's reputation in the competitive healthcare landscape.
What's Next
The filing does not say what happens next.